SCHEMBL5589155

SCHEMBL5589155

CCCCCOc1c(O)c(O)c(CCCC)c(CCCC)c1CCCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR5A1 Q13285 1/20 0.41
ALOX5 P09917 5/20 0.40
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
LTA4H P09960 1/20 0.39
ESR1 P03372 2/20 0.37
THRA P10827 4/20 0.37
THRB P10828 4/20 0.37
GSTA1 P08263 2/20 0.36
GSTP1 P09211 2/20 0.36
CYP19A1 P11511 1/20 0.36
AKR1C4 P17516 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
AKR1C1 Q04828 1/20 0.35
TLR4 O00206 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5588711 0.98 NR5A1 (0.43) NR5A1ALOX5NPC1HPGDMAPK1
SCHEMBL5588384 0.98 NR5A1 (0.43) NR5A1ALOX5NPC1HPGDMAPK1
SCHEMBL5590545 0.98 NR5A1 (0.43) NR5A1ALOX5NPC1HPGDMAPK1
SCHEMBL5588515 0.98 NR5A1 (0.43) NR5A1ALOX5NPC1HPGDMAPK1
SCHEMBL5589331 0.98 NR5A1 (0.43) NR5A1ALOX5NPC1HPGDMAPK1
SCHEMBL5589363 0.96 ALOX5 (0.43) NR5A1ALOX5LTA4HESR1THRA
SCHEMBL5588075 0.95 ALOX5 (0.45) NR5A1ALOX5ESR1THRATHRB
SCHEMBL5589822 0.95 ALOX5 (0.45) NR5A1ALOX5ESR1THRATHRB
SCHEMBL5589837 0.95 ALOX5 (0.45) NR5A1ALOX5ESR1THRATHRB
SCHEMBL5586590 0.95 ALOX5 (0.45) NR5A1ALOX5ESR1THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 NR5A1 2413/4885ALOX5 188/4885NPC1 3851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.